---
schema_version: "secwatch.filing_event.v1"
accession: "0000718937-26-000009"
form_type: "8-K"
ticker: "STAA"
cik: "0000718937"
company_name: "STAAR SURGICAL CO"
filed_at: "2026-04-08T23:59:59+00:00"
generated_at: "2026-05-15T06:57:26.145412+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# STAAR Surgical prelim Q1 2026 net sales expected >$90M, up from $42.6M YoY

## Summary
- Net sales expected to exceed $90M in Q1 2026, more than double prior year's $42.6M.
- China accounted for majority of increase; Americas delivered double-digit growth.
- Significant cost-structure improvement expected to drive meaningful adjusted EBITDA increase.
- Middle East & parts of EMEA/APAC saw sales decline due to geopolitical/macro headwinds.
- Full Q1 results and 10-Q to be reported in early May; no forward guidance provided.

## SEC filing metadata
- accession: 0000718937-26-000009
- form_type: 8-K
- ticker: STAA
- cik: 0000718937
- company_name: STAAR SURGICAL CO
- filed_at: 2026-04-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/718937/000071893726000009/0000718937-26-000009-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/718937/000071893726000009/staa-20260408.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000718937-26-000009
- JSON: https://secwatch.observer/filing/0000718937-26-000009.json
- Plain text: https://secwatch.observer/filing/0000718937-26-000009.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.